The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trastuzumab, pertuzumab and nab-paclitaxel plus pyrotinib or not in neoadjuvant treatment of HER2-positive breast cancer: A multi-center, randomized, open-label, phase II study.
 
Xiaosong Chen
No Relationships to Disclose
 
Jiahui Huang
No Relationships to Disclose
 
Yiwei Tong
No Relationships to Disclose
 
Weili Ren
No Relationships to Disclose
 
Jing Yu
No Relationships to Disclose
 
Weiqi Gao
No Relationships to Disclose
 
Siji Zhu
No Relationships to Disclose
 
Jin Hong
No Relationships to Disclose
 
Jiayi Wu
No Relationships to Disclose
 
Ou Huang
No Relationships to Disclose
 
Jianrong He
No Relationships to Disclose
 
Weiguo Chen
No Relationships to Disclose
 
Yafen Li
No Relationships to Disclose
 
Kunwei Shen
No Relationships to Disclose